Navigation Links
QRxPharma Releases Successful Phase 3 Study Results for 'Dual Opioid' Pain Therapy
Date:5/5/2008

Q8003IR Met Primary Endpoints; Demonstrated Strong Reduction of Pain Intensity

SYDNEY, Australia and BEDMINSTER, N.J., May 5

/PRNewswire-FirstCall/ -- QRxPharma Limited (ASX: QRX), a clinical-stage specialty pharmaceutical company focused on the development and commercialisation of therapies for pain and central nervous system (CNS) disorders, announced today initial Phase 3 efficacy results for Q8003IR, an immediate release dual-opioid product intended for the acute management of moderate to severe pain.

"Initial Phase 3 efficacy data demonstrated statistically significant analgesic activity at all doses tested and reinforces the potential clinical benefit and commercial value of QRxPharma's lead dual-opioid product," said Dr. John Holaday, Managing Director and Chief Executive Officer, QRxPharma. "We are pleased with this study outcome and believe that it demonstrates that the Company remains on target to complete clinical testing for Q8003IR, submit a New Drug Application (NDA) in 2009 and achieve its goal of product launch in 2010."

The double-blind, placebo-controlled study was designed to compare the efficacy and safety of four different dosage regimens of Q8003IR, a fixed ratio morphine/oxycodone combination. 256 patients with moderate to severe pain following surgery (bunionectomy) completed the trial, and it was conducted at six US clinical research sites. The primary efficacy analysis compared the change in pain intensity scores over the 48 hr dosing period (SPID48) in patients receiving Q8003IR vs. placebo.

Among all patients receiving Q8003IR, approximately 50% reported good to excellent global improvement (vs. 13% for placebo) and demonstrated a strong dose-response effect (p<0.001) in reducing pain intensity scores [i.e. the sum of pain intensity difference over 48 hours relative to the first dose (SPID48)] and other measures of analgesic effect. Per treatment group, median doses received every 4 hours
'/>"/>

SOURCE QRxPharma
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. QRxPharma Doses First Patients in Phase III Clinical Trial Program for its Dual Opioid Pain Therapy
2. Immunosyn Releases Wound Healing Photographs From the First Phase Proof of Concept Trial in Europe for Treatment of Diabetic Ulcers With Biopharmeceutical SF-1019
3. TCS Healthcare Technologies Releases Three New Clinical Care Programs Within ACUITY
4. Immunosyn Corporation Releases SF-1019 Study Results
5. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
6. AcroMetrix Releases New OptiQuant(R) HIV-1 Quantification Panel
7. CEL-SCI Corporation Releases Letter to Shareholders
8. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
9. Data Show Preoperative Assessment of Breast Cancer Patients Enables Early Diagnosis, Successful Treatment of Lymphedema
10. Novagali Pharma Successfully Enrolls First Patient in U.S. Phase I Clinical Study with CORTIJECT(R) for Diabetic Macular Edema
11. Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 According to a ... Extraction type (SFE, Cold Pressed, Organic Solvent, & Others), ... Food Supplements, Fragrance, & Others) - Global Trends & ... segments the Amaranth Seed Oil Market with an ... terms of value. The Amaranth Seed Oil Market ...
(Date:8/29/2014)... 29, 2014  United Therapeutics Corporation (NASDAQ: ... for the District of New Jersey ... case against Sandoz, Inc. regarding United Therapeutics, Remodulin ® ... ruled that U.S. Patent No. 6,765,117 is both valid ... marketing its generic product until the expiration of that ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
Breaking Medicine Technology:Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
(Date:8/30/2014)... Recently, Top 10 Best SEO Hosting (Top10BestSEOHosting.com) has ... BlueHost and JustHost ( http://www.justhost.com/track/seohosts ) are great ... high quality web hosting. , “The hosting ... companies who outperform their competitors on hosting features, ... spokesman for Top 10 Best SEO Hosting says, ...
(Date:8/30/2014)... August 31, 2014 Recently, iFitDress.com, one ... its new designs of classy bridesmaid dresses . ... discounts (from 22 percent off to 62 percent off) ... extremely beautiful items. , True enough, iFitDress.com is ... special occasion gowns. The company persists in making trendy ...
(Date:8/30/2014)... Fast hosting is a great ... recently compared many professional web hosting suppliers and ... Arvixe are the suppliers of fastest web hosting ... a good fast hosting supplier. Actually, these companies ... server speed and customer support. People can get ...
(Date:8/30/2014)... Recently, Skmen.com, a well-known clothing manufacturer, has ... . Before the middle of September, all the company’s ... from 15 to 30 percent off. , As ... outfits are carefully made and come with quality guarantees. ... wearers. Skmen.com is popular for its fashionable, high quality ...
(Date:8/30/2014)... Information supplied by insurance companies has been helping ... consumers in 2014. A group of ratess for term ... open system for adults at http://quotespros.com/life-insurance.html . ... year can help the average person to quote a ... from medical histories. The finder tool works under a ...
Breaking Medicine News(10 mins):Health News:Great Web Hosting Suppliers Recently Recommended by Top10BestSEOHosting.com 2Health News:Classy Bridesmaid Dresses Announced By Loved Online Supplier iFitDress.com 2Health News:Fastest Web Hosting Suppliers In 2014 Announced By Top10BestSEOHosting.com 2Health News:Huge Deals On 2014 Long Casual Dresses Unveiled By Skmen.com 2Health News:Term Life Insurance Rates Now Found Nationally by New Insurer Finder Tool 2
... 8 OECD,s latest survey of the United States, to ... the challenges facing the new administration amid a severe economic ... healthcare. The Washington D.C. launch will be held on Capitol ... and will offer first a panel discussion to present the ...
... Join the Faces of Influenza Campaign to Promote Annual Vaccination ... Supports National Influenza Vaccination Week (December 8-14); Urges Immunization Throughout ... KANSAS CITY, MO., Dec. 8 Health experts ... the U.S. Despite this recommendation, influenza immunization rates fall far ...
... Study estimates US treatment costs at $4 billion, similar ... Each year in the United States, treatment of childhood ... for asthma and attention-deficit hyperactivity disorder (ADHD), according to ... Columbus, Ohio. , They analyzed 2003-04 data on children ...
... New York State Health Foundation, Ford Foundation, New York City Investment ... Robert Wood Johnson Foundation Among Investors to Join Leading Advocate for ... for One-Third of America’s Workforce , ... NEW ...
... Dec. 8 Aurora Health Care and Associated Surgical ... surgery centers, announced today that they have entered into ... the surgery center in Franklin. , ... innovative provider organizations that will work in partnership to ...
... from cell death and exerts resistance to chemotherapy has an ... and kill the very tumor cells it usually protects, researchers ... new study published in the Dec. 9 issue of ... called a kinase, that is hyperactive in the majority of ...
Cached Medicine News:Health News:OECD Economic Survey of the United States 2Health News:The American Lung Association of the Central States Encourages Kansas City Residents to See Themselves Among the Many 'Faces' of Influenza 2Health News:The American Lung Association of the Central States Encourages Kansas City Residents to See Themselves Among the Many 'Faces' of Influenza 3Health News:The American Lung Association of the Central States Encourages Kansas City Residents to See Themselves Among the Many 'Faces' of Influenza 4Health News:Childhood Constipation Carries a Big Price Tag 2Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 2Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 3Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 4Health News: Prominent Philanthropies and Businesses Join Freelancers Union to Pioneer New Health Insurance Model 5Health News:Aurora and Associated Surgical & Medical Specialists Announce Surgery Center Joint Venture 2Health News:An Achilles heel in cancer cells 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: